We are live on ! Find out more
INSY

Insys Therapeutics, Inc.
INSY

Delisted

INSY was delisted on the 18th of June, 2019.

Back to rankings

98 hedge funds and large institutions have $51.6M invested in Insys Therapeutics, Inc. in 2019 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 18 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 18

21% more capital invested

Capital invested by funds: $42.5M → $51.6M (+$9.09M)

13% less funds holding

Funds holding: 113 → 98 (-15)

42% less call options, than puts

Call options by funds: $724K | Put options by funds: $1.24M

45% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 29

Holders
98
Holders Change
-15
Holders Change %
-13.27%
% of All Funds
2.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
27
Reduced
18
Closed
29
Calls
$724K
Puts
$1.24M
Net Calls
-$517K
Net Calls Change
-$219K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$3.1M
2
Renaissance Technologies
Renaissance Technologies
New York
+$2.72M
3
Millennium Management
Millennium Management
New York
+$1.26M
4
PAM
Panagora Asset Management
Massachusetts
+$688K
5
Citadel Advisors
Citadel Advisors
Florida
+$480K

Top Sellers

Rank Fund Capital Flow
1
EMG
ETF Managers Group
New Jersey
-$5.08M
2
Norges Bank
Norges Bank
Norway
-$2.19M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$888K
4
BlackRock
BlackRock
New York
-$544K
5
JP Morgan Chase
JP Morgan Chase
New York
-$366K
Name Holding Trade Value Shares
Change 		Change in
Stake
RIA
76
Realta Investment Advisors
Delaware
$3K +$2.89K +611 New
Daiwa Securities Group
77
Daiwa Securities Group
Japan
$2K – – –
LFG
78
Larson Financial Group
Missouri
$2K – – –
NSIM
79
North Star Investment Management
Illinois
$2K – – –
RIA
80
RPG Investment Advisory
California
$2K – – –
VRM
81
Vectors Research Management
New York
$2K – – –
AIC
82
Ameritas Investment Company
Nebraska
$1K -$2.77K -585 -84%
IA
83
IFP Advisors
Florida
$1K -$237 -50 -20%
AF
84
Advisornet Financial
Minnesota
$1K – – –
NFG
85
Next Financial Group
Texas
$1K – – –
Northwestern Mutual Wealth Management
86
Northwestern Mutual Wealth Management
Wisconsin
$1K – – –
SIAP
87
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
$1K – – –
GSWM
88
Golden State Wealth Management
California
$1K +$947 +200 New
NFH
89
NEXT Financial Holdings
Texas
$1K +$947 +200 New
FDCDDQ
90
Federation des caisses Desjardins du Quebec
Quebec, Canada
$554 – – –
RE
91
RBC Europe
United Kingdom
$300 – – –
EMG
92
ETF Managers Group
New Jersey
– -$5.08M -1,471,368 Closed
Norges Bank
93
Norges Bank
Norway
– -$2.19M -627,077 Closed
JC
94
JBF Capital
Colorado
– -$350K -100,000 Closed
Jacobs Levy Equity Management
95
Jacobs Levy Equity Management
New Jersey
– -$279K -79,700 Closed
EGM
96
Engineers Gate Manager
New York
– -$222K -63,511 Closed
Squarepoint
97
Squarepoint
New York
– -$212K -60,513 Closed
JG
98
Jefferies Group
New York
– -$166K -47,403 Closed
Two Sigma Investments
99
Two Sigma Investments
New York
– -$156K -44,700 Closed
Invesco
100
Invesco
Georgia
– -$135K -38,695 Closed
1 2 3
4
5

INSY Hedge Fund Activity: Q1 2019 in Review

98 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Insys Therapeutics, Inc. (INSY) for Q1 2019, worth a combined $51.6M — up 21% from $42.5M a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of INSY and 16 opened new positions — a net loss of 13 holders — while 18 trimmed existing stakes and 27 added.

The largest buyer was Vanguard Group, adding an estimated $3.1M. The largest seller was ETF Managers Group, exiting entirely with an estimated $5.08M sold.

  • 98 institutional investors held Insys Therapeutics, Inc. (INSY) as of Q1 2019, down from 113 in Q4 2018.
  • Funds reported $51.6M of Insys Therapeutics, Inc. stock for Q1 2019, up 21% quarter-over-quarter.
  • 16 funds opened new Insys Therapeutics, Inc. positions in Q1 2019 and 29 closed out, a net change of -13 holders.
  • The largest Insys Therapeutics, Inc. buyer in Q1 2019 was Vanguard Group, an estimated $3.1M added.
  • The largest Insys Therapeutics, Inc. seller in Q1 2019 was ETF Managers Group, an estimated $5.08M sold.

Based on aggregated 13F filings for Q1 2019.